NCT04141800View on ClinicalTrials.gov

Spanish Study of Hyperkalaemia Incidence and Prognosis in Patients With Heart Failure and Reduced Ejection Fraction

CompletedOBSERVATIONAL
Enrollment

565

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Heart Failure With Reduced Ejection FractionHyperkalemia
Trial Locations (1)

Unknown

Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Spanish Society of Cardiology

OTHER